AMGN - Company ID 0000318154
The table below shows AMGEN INC's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $36.75B | $33.42B | $28.19B | $26.32B | $25.98B | $25.42B |
| Cost of revenue | $12.04B | $12.86B | $8.45B | $6.41B | $6.45B | $6.16B |
| Gross profit | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - |
| SG&A |
AMGEN INC reported annual revenue of $36.75B for fiscal year 2025. That is up 10.0% from $33.42B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $22.99B (FY 2016) to $36.75B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $7.05B |
| $7.10B |
| $6.18B |
| $5.41B |
| $5.37B |
| $5.73B |
| Operating income | $9.08B | $7.26B | $7.90B | $9.57B | $7.64B | $9.14B |
| Income tax | $1.26B | $519.00M | $1.14B | $794.00M | $808.00M | $869.00M |
| Net income | $7.71B | $4.09B | $6.72B | $6.55B | $5.89B | $7.26B |
| EPS (diluted) | $14.23 | $7.56 | $12.49 | $12.11 | $10.28 | $12.31 |